Pursuant to Regulation 47 of SEBI Listing Regulations, 2015 enclosed herewith copies of the Newspaper publications providing Audited Financial Results for the Quarter ended June 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 23 2025
- Financial Results For The Quarter Ended June 30, 2025.
- Board Meeting Outcome for Financial Results For The Quarter Ended June 30, 2025.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 16 2025
- Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2025.
Later from Venmax Drugs & Pharmaceuticals
- Board Meeting Intimation for Allotment Of Equity Shares Pursuant To Conversion Of Convertible Equity Share Warrants.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 08 2025
- Board Meeting Outcome for Outcome Of Board Meeting For Conversion Of Share Warrants And Allotment Of Equity Shares
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 16 2025
- Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals